IBDEI0FR ; ; 03-MAY-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.4,1326,0)
;;=W DIAGNOSES^23^97
;;^UTILITY(U,$J,358.4,1327,0)
;;=B DIAGNOSES^3^97
;;^UTILITY(U,$J,358.4,1328,0)
;;=G DIAGNOSES^8^97
;;^UTILITY(U,$J,358.4,1329,0)
;;=H DIAGNOSES^8^97
;;^UTILITY(U,$J,358.4,1330,0)
;;=L DIAGNOSES^12^97
;;^UTILITY(U,$J,358.4,1331,0)
;;=O DIAGNOSES^15^97
;;^UTILITY(U,$J,358.4,1332,0)
;;=U DIAGNOSES^21^97
;;^UTILITY(U,$J,358.4,1333,0)
;;=Z DIAGNOSES^25^97
;;^UTILITY(U,$J,358.4,1334,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^19^97
;;^UTILITY(U,$J,358.4,1335,0)
;;=MOST COMMON DX^1^97
;;^UTILITY(U,$J,358.4,1336,0)
;;=TELEHEALTH FACILITY FEE^1^98
;;^UTILITY(U,$J,358.4,1337,0)
;;=INFECTIOUS DISEASE^12^99
;;^UTILITY(U,$J,358.4,1338,0)
;;=NEOPLASMS^14^99
;;^UTILITY(U,$J,358.4,1339,0)
;;=HEMATOLOGY/ENDOCRINE^9^99
;;^UTILITY(U,$J,358.4,1340,0)
;;=MENTAL HEALTH^13^99
;;^UTILITY(U,$J,358.4,1341,0)
;;=NEUROLOGY^15^99
;;^UTILITY(U,$J,358.4,1342,0)
;;=GI^7^99
;;^UTILITY(U,$J,358.4,1343,0)
;;=CARDIOLOGY^3^99
;;^UTILITY(U,$J,358.4,1344,0)
;;=HERNIA^10^99
;;^UTILITY(U,$J,358.4,1345,0)
;;=GENITOURINARY^6^99
;;^UTILITY(U,$J,358.4,1346,0)
;;=SKIN^22^99
;;^UTILITY(U,$J,358.4,1347,0)
;;=ENT^4^99
;;^UTILITY(U,$J,358.4,1348,0)
;;=RHEUMATOLOGY/ORTHO^20^99
;;^UTILITY(U,$J,358.4,1349,0)
;;=RESPIRATORY^19^99
;;^UTILITY(U,$J,358.4,1350,0)
;;=SIGNS/SYMPTOMS/HX OF^21^99
;;^UTILITY(U,$J,358.4,1351,0)
;;=VASCULAR^24^99
;;^UTILITY(U,$J,358.4,1352,0)
;;=ANTICOAGULATION^2^99
;;^UTILITY(U,$J,358.4,1353,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^23^99
;;^UTILITY(U,$J,358.4,1354,0)
;;=ALLERGY/ASTHMA^1^99
;;^UTILITY(U,$J,358.4,1355,0)
;;=EYES^5^99
;;^UTILITY(U,$J,358.4,1356,0)
;;=HEADACHES^8^99
;;^UTILITY(U,$J,358.4,1357,0)
;;=IMMUNOLOGY^11^99
;;^UTILITY(U,$J,358.4,1358,0)
;;=NICOTINE DEPENDENCE^16^99
;;^UTILITY(U,$J,358.4,1359,0)
;;=PERSONAL HX/STATUS^18^99
;;^UTILITY(U,$J,358.4,1360,0)
;;=NEW PATIENT^2^100
;;^UTILITY(U,$J,358.4,1361,0)
;;=ESTABLISHED PATIENT^1^100
;;^UTILITY(U,$J,358.4,1362,0)
;;=CONSULTATIONS^3^100
;;^UTILITY(U,$J,358.4,1363,0)
;;=POST OP VISIT (GLOBAL)^4^100
;;^UTILITY(U,$J,358.4,1364,0)
;;=BONE MARROW^1^101
;;^UTILITY(U,$J,358.4,1365,0)
;;=HEART^2^101
;;^UTILITY(U,$J,358.4,1366,0)
;;=HEART-LUNG^3^101
;;^UTILITY(U,$J,358.4,1367,0)
;;=LIVER^4^101
;;^UTILITY(U,$J,358.4,1368,0)
;;=LUNG^5^101
;;^UTILITY(U,$J,358.4,1369,0)
;;=PANCREAS^7^101
;;^UTILITY(U,$J,358.4,1370,0)
;;=RENAL^9^101
;;^UTILITY(U,$J,358.4,1371,0)
;;=REPAIR/RESECTION OF DONOR HEART^10^101
;;^UTILITY(U,$J,358.4,1372,0)
;;=PROLONGED SERVICE^8^101
;;^UTILITY(U,$J,358.4,1373,0)
;;=MODERATE SEDATION^6^101
;;^UTILITY(U,$J,358.4,1374,0)
;;=CHRONIC PULM. HEART DISEASE^2^102
;;^UTILITY(U,$J,358.4,1375,0)
;;=DIS. OF BLOOD/FORMING ORGA^4^102
;;^UTILITY(U,$J,358.4,1376,0)
;;=HERNIA^7^102
;;^UTILITY(U,$J,358.4,1377,0)
;;=KIDNEY/PANCREAS^8^102
;;^UTILITY(U,$J,358.4,1378,0)
;;=LIVER^9^102
;;^UTILITY(U,$J,358.4,1379,0)
;;=LUNG^10^102
;;^UTILITY(U,$J,358.4,1380,0)
;;=MALIGNANT LYMPH & HEMATOP^11^102
;;^UTILITY(U,$J,358.4,1381,0)
;;=MALIGNANT NEOPLASMS SOLID ORGANS^12^102
;;^UTILITY(U,$J,358.4,1382,0)
;;=METABOLIC DISORDERS^13^102
;;^UTILITY(U,$J,358.4,1383,0)
;;=SYMPTOMS/SIGNS^14^102
;;^UTILITY(U,$J,358.4,1384,0)
;;=COMPLICATIONS OF SURGERY^3^102
;;^UTILITY(U,$J,358.4,1385,0)
;;=DONORS OF ORGANS AND TISSUES^5^102
;;^UTILITY(U,$J,358.4,1386,0)
;;=HEART^6^102
;;^UTILITY(U,$J,358.4,1387,0)
;;=AFTERCARE FOLLOWING TRANSPLANT^1^102
;;^UTILITY(U,$J,358.4,1388,0)
;;=NEW PATIENT^2^103
;;^UTILITY(U,$J,358.4,1389,0)
;;=ESTABLISHED PATIENT^1^103
;;^UTILITY(U,$J,358.4,1390,0)
;;=POST-OP (GLOBAL)^3^103
;;^UTILITY(U,$J,358.4,1391,0)
;;=JOINT INJECTIONS^15^104
;;^UTILITY(U,$J,358.4,1392,0)
;;=TENDON INJECTION^26^104
;;^UTILITY(U,$J,358.4,1393,0)
;;=SKIN PROCEDURES^24^104
;;^UTILITY(U,$J,358.4,1394,0)
;;=ADMINISTRATION OF INJ MEDICATIONS^2^104
;;^UTILITY(U,$J,358.4,1395,0)
;;=EKG^11^104
;;^UTILITY(U,$J,358.4,1396,0)
;;=NOSEBLEEDS^16^104
;;^UTILITY(U,$J,358.4,1397,0)
;;=REMOVAL FB IN EAR^18^104
;;^UTILITY(U,$J,358.4,1398,0)
;;=INJECTABLE MEDICATIONS^14^104
;;^UTILITY(U,$J,358.4,1399,0)
;;=INFUSION MEDICATIONS^12^104
;;^UTILITY(U,$J,358.4,1400,0)
;;=ADMINISTRATION OF IV MEDICATIONS^3^104
;;^UTILITY(U,$J,358.4,1401,0)
;;=INHALATION SOLUTIONS THRU DME^13^104
;;^UTILITY(U,$J,358.4,1402,0)
;;=ADMINISTRATION OF DME^1^104
;;^UTILITY(U,$J,358.4,1403,0)
;;=DEMO OF METERED INHALER^10^104
;;^UTILITY(U,$J,358.4,1404,0)
;;=BLOOD TESTS^6^104
;;^UTILITY(U,$J,358.4,1405,0)
;;=BLADDER ^5^104
;;^UTILITY(U,$J,358.4,1406,0)
;;=BLOOD TRANSFUSION^7^104
;;^UTILITY(U,$J,358.4,1407,0)
;;=AIRWAY TREATMENTS^4^104
;;^UTILITY(U,$J,358.4,1408,0)
;;=BURN TREATMENT^8^104
;;^UTILITY(U,$J,358.4,1409,0)
;;=TB TEST^25^104
;;^UTILITY(U,$J,358.4,1410,0)
;;=REPAIR-SIMPLE-SCALP,NK,TRUNK^20^104
;;^UTILITY(U,$J,358.4,1411,0)
;;=REPAIR-SIMPLE-FACE,MUCOUS^19^104
;;^UTILITY(U,$J,358.4,1412,0)
;;=REPAIR-INTERM-SCALP,TRUNK^23^104
;;^UTILITY(U,$J,358.4,1413,0)
;;=REPAIR-INTERM-NK,HAND,FT,GENITALIA^22^104
;;^UTILITY(U,$J,358.4,1414,0)
;;=REPAIR-INTERM-FACE,MUCOUS^21^104
;;^UTILITY(U,$J,358.4,1415,0)
;;=OTHER^27^104
;;^UTILITY(U,$J,358.4,1416,0)
;;=PSYCHIATRY^17^104
;;^UTILITY(U,$J,358.4,1417,0)
;;=COVID-19 RELATED^9^104
;;^UTILITY(U,$J,358.4,1418,0)
;;=PC COMMON DIAGNOSES^1^105
;;^UTILITY(U,$J,358.4,1419,0)
;;=ADMINISTRATIVE TOPICS^15^105
;;^UTILITY(U,$J,358.4,1420,0)
;;=ANGINA^16^105
;;^UTILITY(U,$J,358.4,1421,0)
;;=ATHEROSCLEROSIS^17^105
;;^UTILITY(U,$J,358.4,1422,0)
;;=CARDIOVASCULAR^18^105
;;^UTILITY(U,$J,358.4,1423,0)
;;=DERMATOLOGY^22^105
;;^UTILITY(U,$J,358.4,1424,0)
;;=EAR DISORDERS^24^105
;;^UTILITY(U,$J,358.4,1425,0)
;;=EENT^25^105
;;^UTILITY(U,$J,358.4,1426,0)
;;=ENDOCRINE/METABOLIC^26^105
;;^UTILITY(U,$J,358.4,1427,0)
;;=EYE DISORDERS^27^105
;;^UTILITY(U,$J,358.4,1428,0)
;;=EYE INJURY^28^105
;;^UTILITY(U,$J,358.4,1429,0)
;;=GASTROENTEROLOGY^29^105
;;^UTILITY(U,$J,358.4,1430,0)
;;=GU/RENAL^30^105
;;^UTILITY(U,$J,358.4,1431,0)
;;=HEADACHE^31^105
;;^UTILITY(U,$J,358.4,1432,0)
;;=HEART VALVE DISEASE^32^105
;;^UTILITY(U,$J,358.4,1433,0)
;;=HEMATOLOGY/ONCOLOGY^33^105
;;^UTILITY(U,$J,358.4,1434,0)
;;=HISTORY OF ILLNESS^34^105
;;^UTILITY(U,$J,358.4,1435,0)
;;=INFECTIOUS DISEASE^35^105
;;^UTILITY(U,$J,358.4,1436,0)
;;=LIVER DISEASE^36^105
;;^UTILITY(U,$J,358.4,1437,0)
;;=MENTAL HEALTH^38^105
;;^UTILITY(U,$J,358.4,1438,0)
;;=MOVEMENT DISORDERS^39^105
;;^UTILITY(U,$J,358.4,1439,0)
;;=MUSCULOSKELETAL^40^105
;;^UTILITY(U,$J,358.4,1440,0)
;;=NEUROLOGY^41^105
;;^UTILITY(U,$J,358.4,1441,0)
;;=PAIN^42^105
;;^UTILITY(U,$J,358.4,1442,0)
;;=PREVENTIVE HEALTH^43^105
;;^UTILITY(U,$J,358.4,1443,0)
;;=PULMONARY^44^105
;;^UTILITY(U,$J,358.4,1444,0)
;;=SEXUAL TRAUMA^45^105
;;^UTILITY(U,$J,358.4,1445,0)
;;=SIGNS,SYMPTOMS,CONDITIONS^46^105
;;^UTILITY(U,$J,358.4,1446,0)
;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^47^105
;;^UTILITY(U,$J,358.4,1447,0)
;;=SUBSTANCE DISORDERS^48^105
;;^UTILITY(U,$J,358.4,1448,0)
;;=VARICOSE VEINS^50^105
;;^UTILITY(U,$J,358.4,1449,0)
;;=WOMEN'S HEALTH^51^105
;;^UTILITY(U,$J,358.4,1450,0)
;;=WOUNDS-INITIAL ENCOUNTER^52^105
;;^UTILITY(U,$J,358.4,1451,0)
;;=COMA^20^105
;;^UTILITY(U,$J,358.4,1452,0)
;;=CAUSES OF INJURY^19^105
;;^UTILITY(U,$J,358.4,1453,0)
;;=DEMENTIA^21^105
;;^UTILITY(U,$J,358.4,1454,0)
;;=LONG TERM CURRENT DRUG THERAPY^37^105
;;^UTILITY(U,$J,358.4,1455,0)
;;=ACQUIRED ABSENCE OF BODY PART(S)^2^105
;;^UTILITY(U,$J,358.4,1456,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^49^105
;;^UTILITY(U,$J,358.4,1457,0)
;;=ACSC ACUTE KIDNEY FAILURE^3^105
;;^UTILITY(U,$J,358.4,1458,0)
;;=ACSC ANGINA^4^105
;;^UTILITY(U,$J,358.4,1459,0)
;;=ACSC ASTHMA/BRONCHITIS/COPD^5^105
;;^UTILITY(U,$J,358.4,1460,0)
;;=ACSC CHF^6^105
;;^UTILITY(U,$J,358.4,1461,0)
;;=ACSC DEHYDRATION^7^105
;;^UTILITY(U,$J,358.4,1462,0)
;;=ACSC DIABETES TYPE 1^8^105
;;^UTILITY(U,$J,358.4,1463,0)
;;=ACSC DIABETES TYPE 2^9^105
;;^UTILITY(U,$J,358.4,1464,0)
;;=ACSC HYPERTENSION^10^105
;;^UTILITY(U,$J,358.4,1465,0)
;;=ACSC INFECTIOUS GASTROENTERITIS^11^105
;;^UTILITY(U,$J,358.4,1466,0)
;;=ACSC PNEUMONIA^12^105
;;^UTILITY(U,$J,358.4,1467,0)
;;=ACSC UTI^13^105
;;^UTILITY(U,$J,358.4,1468,0)
;;=ACSC VIRAL ENTERITIS^14^105
;;^UTILITY(U,$J,358.4,1469,0)
;;=E-CIG/VAPE LUNG INJURY^23^105
;;^UTILITY(U,$J,358.4,1470,0)
;;=HEALTH/BEHAVIOR ASSESSMENT^1^106
;;^UTILITY(U,$J,358.4,1471,0)
;;=HEALTH/BEHAVIOR INTERVENTION^2^106
;;^UTILITY(U,$J,358.4,1472,0)
;;=PC COMMON DIAGNOSES^1^107
;;^UTILITY(U,$J,358.4,1473,0)
;;=ADMINISTRATIVE TOPICS^15^107
;;^UTILITY(U,$J,358.4,1474,0)
;;=ANGINA^16^107
;;^UTILITY(U,$J,358.4,1475,0)
;;=ATHEROSCLEROSIS^17^107
;;^UTILITY(U,$J,358.4,1476,0)
;;=CARDIOVASCULAR^18^107
;;^UTILITY(U,$J,358.4,1477,0)
;;=DERMATOLOGY^22^107
;;^UTILITY(U,$J,358.4,1478,0)
;;=EAR DISORDERS^24^107
;;^UTILITY(U,$J,358.4,1479,0)
;;=EENT^25^107
;;^UTILITY(U,$J,358.4,1480,0)
;;=ENDOCRINE/METABOLIC^26^107
;;^UTILITY(U,$J,358.4,1481,0)
;;=EYE DISORDERS^27^107
;;^UTILITY(U,$J,358.4,1482,0)
;;=EYE INJURY^28^107
;;^UTILITY(U,$J,358.4,1483,0)
;;=GASTROENTEROLOGY^29^107
;;^UTILITY(U,$J,358.4,1484,0)
;;=GU/RENAL^30^107
;;^UTILITY(U,$J,358.4,1485,0)
;;=HEADACHE^31^107
;;^UTILITY(U,$J,358.4,1486,0)
;;=HEART VALVE DISEASE^32^107
;;^UTILITY(U,$J,358.4,1487,0)
;;=HEMATOLOGY/ONCOLOGY^33^107
;;^UTILITY(U,$J,358.4,1488,0)
;;=HISTORY OF ILLNESS^34^107
;;^UTILITY(U,$J,358.4,1489,0)
;;=INFECTIOUS DISEASE^35^107
;;^UTILITY(U,$J,358.4,1490,0)
;;=LIVER DISEASE^36^107
;;^UTILITY(U,$J,358.4,1491,0)
;;=MENTAL HEALTH^38^107
;;^UTILITY(U,$J,358.4,1492,0)
;;=MOVEMENT DISORDERS^39^107
;;^UTILITY(U,$J,358.4,1493,0)
;;=MUSCULOSKELETAL^40^107
;;^UTILITY(U,$J,358.4,1494,0)
;;=NEUROLOGY^41^107
;;^UTILITY(U,$J,358.4,1495,0)
;;=PAIN^42^107
;;^UTILITY(U,$J,358.4,1496,0)
;;=PREVENTIVE HEALTH^43^107
;;^UTILITY(U,$J,358.4,1497,0)
;;=PULMONARY^44^107
;;^UTILITY(U,$J,358.4,1498,0)
;;=SEXUAL TRAUMA^45^107
;;^UTILITY(U,$J,358.4,1499,0)
;;=SIGNS,SYMPTOMS,CONDITIONS^46^107
;;^UTILITY(U,$J,358.4,1500,0)
;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^47^107
;;^UTILITY(U,$J,358.4,1501,0)
;;=SUBSTANCE DISORDERS^48^107
;;^UTILITY(U,$J,358.4,1502,0)
;;=VARICOSE VEINS^50^107
;;^UTILITY(U,$J,358.4,1503,0)
;;=WOMEN'S HEALTH^51^107
;;^UTILITY(U,$J,358.4,1504,0)
;;=WOUNDS-INITIAL ENCOUNTER^52^107
;;^UTILITY(U,$J,358.4,1505,0)
;;=COMA^20^107
;;^UTILITY(U,$J,358.4,1506,0)
;;=CAUSES OF INJURY^19^107
;;^UTILITY(U,$J,358.4,1507,0)
;;=DEMENTIA^21^107
;;^UTILITY(U,$J,358.4,1508,0)
;;=LONG TERM CURRENT DRUG THERAPY^37^107
;;^UTILITY(U,$J,358.4,1509,0)
;;=ACQUIRED ABSENCE OF BODY PART(S)^2^107
;;^UTILITY(U,$J,358.4,1510,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^49^107
;;^UTILITY(U,$J,358.4,1511,0)
;;=ACSC ACUTE KIDNEY FAILURE^3^107
;;^UTILITY(U,$J,358.4,1512,0)
;;=ACSC ANGINA^4^107
;;^UTILITY(U,$J,358.4,1513,0)
;;=ACSC ASTHMA/BRONCHITIS/COPD^5^107
;;^UTILITY(U,$J,358.4,1514,0)
;;=ACSC CHF^6^107
;;^UTILITY(U,$J,358.4,1515,0)
;;=ACSC DEHYDRATION^7^107
;;^UTILITY(U,$J,358.4,1516,0)
;;=ACSC DIABETES TYPE 1^8^107
;;^UTILITY(U,$J,358.4,1517,0)
;;=ACSC DIABETES TYPE 2^9^107
;;^UTILITY(U,$J,358.4,1518,0)
;;=ACSC HYPERTENSION^10^107
;;^UTILITY(U,$J,358.4,1519,0)
;;=ACSC INFECTIOUS GASTROENTERITIS^11^107
;;^UTILITY(U,$J,358.4,1520,0)
;;=ACSC PNEUMONIA^12^107
;;^UTILITY(U,$J,358.4,1521,0)
;;=ACSC UTI^13^107
;;^UTILITY(U,$J,358.4,1522,0)
;;=ACSC VIRAL ENTERITIS^14^107
;;^UTILITY(U,$J,358.4,1523,0)
;;=E-CIG/VAPE LUNG INJURY^23^107
;;^UTILITY(U,$J,358.4,1524,0)
;;=COVID-19 CONFIRMED^2^108
;;^UTILITY(U,$J,358.4,1525,0)
;;=COVID-19 EXPOSURE^3^108
;;^UTILITY(U,$J,358.4,1526,0)
;;=COVID-19 RELATED COND/SYMP^5^108
;;^UTILITY(U,$J,358.4,1527,0)
;;=COVID-19 SCREEN^1^108
;;^UTILITY(U,$J,358.4,1528,0)
;;=COVID-19 PRE-OP^4^108
;;^UTILITY(U,$J,358.4,1529,0)
;;=COVID-19 VACCINE STATUS^6^108
;;^UTILITY(U,$J,358.4,1530,0)
;;=COVID-19 ^1^109
;;^UTILITY(U,$J,358.4,1531,0)
;;=COVID-19 CONFIRMED^2^110
;;^UTILITY(U,$J,358.4,1532,0)
;;=COVID-19 EXPOSURE^3^110
;;^UTILITY(U,$J,358.4,1533,0)
;;=COVID-19 RELATED COND/SYMP^5^110
;;^UTILITY(U,$J,358.4,1534,0)
;;=COVID-19 SCREEN^1^110
;;^UTILITY(U,$J,358.4,1535,0)
;;=COVID-19 PRE-OP^4^110
;;^UTILITY(U,$J,358.4,1536,0)
;;=COVID-19 VACCINE STATUS^6^110
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0FR 13028 printed Nov 22, 2024@16:58:01 Page 2
IBDEI0FR ; ; 03-MAY-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
+2 if 'DIFQR(358.4)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.4,1326,0)
+2 ;;=W DIAGNOSES^23^97
+3 ;;^UTILITY(U,$J,358.4,1327,0)
+4 ;;=B DIAGNOSES^3^97
+5 ;;^UTILITY(U,$J,358.4,1328,0)
+6 ;;=G DIAGNOSES^8^97
+7 ;;^UTILITY(U,$J,358.4,1329,0)
+8 ;;=H DIAGNOSES^8^97
+9 ;;^UTILITY(U,$J,358.4,1330,0)
+10 ;;=L DIAGNOSES^12^97
+11 ;;^UTILITY(U,$J,358.4,1331,0)
+12 ;;=O DIAGNOSES^15^97
+13 ;;^UTILITY(U,$J,358.4,1332,0)
+14 ;;=U DIAGNOSES^21^97
+15 ;;^UTILITY(U,$J,358.4,1333,0)
+16 ;;=Z DIAGNOSES^25^97
+17 ;;^UTILITY(U,$J,358.4,1334,0)
+18 ;;=SUICIDE IDEATIONS/ATTEMPTS^19^97
+19 ;;^UTILITY(U,$J,358.4,1335,0)
+20 ;;=MOST COMMON DX^1^97
+21 ;;^UTILITY(U,$J,358.4,1336,0)
+22 ;;=TELEHEALTH FACILITY FEE^1^98
+23 ;;^UTILITY(U,$J,358.4,1337,0)
+24 ;;=INFECTIOUS DISEASE^12^99
+25 ;;^UTILITY(U,$J,358.4,1338,0)
+26 ;;=NEOPLASMS^14^99
+27 ;;^UTILITY(U,$J,358.4,1339,0)
+28 ;;=HEMATOLOGY/ENDOCRINE^9^99
+29 ;;^UTILITY(U,$J,358.4,1340,0)
+30 ;;=MENTAL HEALTH^13^99
+31 ;;^UTILITY(U,$J,358.4,1341,0)
+32 ;;=NEUROLOGY^15^99
+33 ;;^UTILITY(U,$J,358.4,1342,0)
+34 ;;=GI^7^99
+35 ;;^UTILITY(U,$J,358.4,1343,0)
+36 ;;=CARDIOLOGY^3^99
+37 ;;^UTILITY(U,$J,358.4,1344,0)
+38 ;;=HERNIA^10^99
+39 ;;^UTILITY(U,$J,358.4,1345,0)
+40 ;;=GENITOURINARY^6^99
+41 ;;^UTILITY(U,$J,358.4,1346,0)
+42 ;;=SKIN^22^99
+43 ;;^UTILITY(U,$J,358.4,1347,0)
+44 ;;=ENT^4^99
+45 ;;^UTILITY(U,$J,358.4,1348,0)
+46 ;;=RHEUMATOLOGY/ORTHO^20^99
+47 ;;^UTILITY(U,$J,358.4,1349,0)
+48 ;;=RESPIRATORY^19^99
+49 ;;^UTILITY(U,$J,358.4,1350,0)
+50 ;;=SIGNS/SYMPTOMS/HX OF^21^99
+51 ;;^UTILITY(U,$J,358.4,1351,0)
+52 ;;=VASCULAR^24^99
+53 ;;^UTILITY(U,$J,358.4,1352,0)
+54 ;;=ANTICOAGULATION^2^99
+55 ;;^UTILITY(U,$J,358.4,1353,0)
+56 ;;=SUICIDE IDEATIONS/ATTEMPTS^23^99
+57 ;;^UTILITY(U,$J,358.4,1354,0)
+58 ;;=ALLERGY/ASTHMA^1^99
+59 ;;^UTILITY(U,$J,358.4,1355,0)
+60 ;;=EYES^5^99
+61 ;;^UTILITY(U,$J,358.4,1356,0)
+62 ;;=HEADACHES^8^99
+63 ;;^UTILITY(U,$J,358.4,1357,0)
+64 ;;=IMMUNOLOGY^11^99
+65 ;;^UTILITY(U,$J,358.4,1358,0)
+66 ;;=NICOTINE DEPENDENCE^16^99
+67 ;;^UTILITY(U,$J,358.4,1359,0)
+68 ;;=PERSONAL HX/STATUS^18^99
+69 ;;^UTILITY(U,$J,358.4,1360,0)
+70 ;;=NEW PATIENT^2^100
+71 ;;^UTILITY(U,$J,358.4,1361,0)
+72 ;;=ESTABLISHED PATIENT^1^100
+73 ;;^UTILITY(U,$J,358.4,1362,0)
+74 ;;=CONSULTATIONS^3^100
+75 ;;^UTILITY(U,$J,358.4,1363,0)
+76 ;;=POST OP VISIT (GLOBAL)^4^100
+77 ;;^UTILITY(U,$J,358.4,1364,0)
+78 ;;=BONE MARROW^1^101
+79 ;;^UTILITY(U,$J,358.4,1365,0)
+80 ;;=HEART^2^101
+81 ;;^UTILITY(U,$J,358.4,1366,0)
+82 ;;=HEART-LUNG^3^101
+83 ;;^UTILITY(U,$J,358.4,1367,0)
+84 ;;=LIVER^4^101
+85 ;;^UTILITY(U,$J,358.4,1368,0)
+86 ;;=LUNG^5^101
+87 ;;^UTILITY(U,$J,358.4,1369,0)
+88 ;;=PANCREAS^7^101
+89 ;;^UTILITY(U,$J,358.4,1370,0)
+90 ;;=RENAL^9^101
+91 ;;^UTILITY(U,$J,358.4,1371,0)
+92 ;;=REPAIR/RESECTION OF DONOR HEART^10^101
+93 ;;^UTILITY(U,$J,358.4,1372,0)
+94 ;;=PROLONGED SERVICE^8^101
+95 ;;^UTILITY(U,$J,358.4,1373,0)
+96 ;;=MODERATE SEDATION^6^101
+97 ;;^UTILITY(U,$J,358.4,1374,0)
+98 ;;=CHRONIC PULM. HEART DISEASE^2^102
+99 ;;^UTILITY(U,$J,358.4,1375,0)
+100 ;;=DIS. OF BLOOD/FORMING ORGA^4^102
+101 ;;^UTILITY(U,$J,358.4,1376,0)
+102 ;;=HERNIA^7^102
+103 ;;^UTILITY(U,$J,358.4,1377,0)
+104 ;;=KIDNEY/PANCREAS^8^102
+105 ;;^UTILITY(U,$J,358.4,1378,0)
+106 ;;=LIVER^9^102
+107 ;;^UTILITY(U,$J,358.4,1379,0)
+108 ;;=LUNG^10^102
+109 ;;^UTILITY(U,$J,358.4,1380,0)
+110 ;;=MALIGNANT LYMPH & HEMATOP^11^102
+111 ;;^UTILITY(U,$J,358.4,1381,0)
+112 ;;=MALIGNANT NEOPLASMS SOLID ORGANS^12^102
+113 ;;^UTILITY(U,$J,358.4,1382,0)
+114 ;;=METABOLIC DISORDERS^13^102
+115 ;;^UTILITY(U,$J,358.4,1383,0)
+116 ;;=SYMPTOMS/SIGNS^14^102
+117 ;;^UTILITY(U,$J,358.4,1384,0)
+118 ;;=COMPLICATIONS OF SURGERY^3^102
+119 ;;^UTILITY(U,$J,358.4,1385,0)
+120 ;;=DONORS OF ORGANS AND TISSUES^5^102
+121 ;;^UTILITY(U,$J,358.4,1386,0)
+122 ;;=HEART^6^102
+123 ;;^UTILITY(U,$J,358.4,1387,0)
+124 ;;=AFTERCARE FOLLOWING TRANSPLANT^1^102
+125 ;;^UTILITY(U,$J,358.4,1388,0)
+126 ;;=NEW PATIENT^2^103
+127 ;;^UTILITY(U,$J,358.4,1389,0)
+128 ;;=ESTABLISHED PATIENT^1^103
+129 ;;^UTILITY(U,$J,358.4,1390,0)
+130 ;;=POST-OP (GLOBAL)^3^103
+131 ;;^UTILITY(U,$J,358.4,1391,0)
+132 ;;=JOINT INJECTIONS^15^104
+133 ;;^UTILITY(U,$J,358.4,1392,0)
+134 ;;=TENDON INJECTION^26^104
+135 ;;^UTILITY(U,$J,358.4,1393,0)
+136 ;;=SKIN PROCEDURES^24^104
+137 ;;^UTILITY(U,$J,358.4,1394,0)
+138 ;;=ADMINISTRATION OF INJ MEDICATIONS^2^104
+139 ;;^UTILITY(U,$J,358.4,1395,0)
+140 ;;=EKG^11^104
+141 ;;^UTILITY(U,$J,358.4,1396,0)
+142 ;;=NOSEBLEEDS^16^104
+143 ;;^UTILITY(U,$J,358.4,1397,0)
+144 ;;=REMOVAL FB IN EAR^18^104
+145 ;;^UTILITY(U,$J,358.4,1398,0)
+146 ;;=INJECTABLE MEDICATIONS^14^104
+147 ;;^UTILITY(U,$J,358.4,1399,0)
+148 ;;=INFUSION MEDICATIONS^12^104
+149 ;;^UTILITY(U,$J,358.4,1400,0)
+150 ;;=ADMINISTRATION OF IV MEDICATIONS^3^104
+151 ;;^UTILITY(U,$J,358.4,1401,0)
+152 ;;=INHALATION SOLUTIONS THRU DME^13^104
+153 ;;^UTILITY(U,$J,358.4,1402,0)
+154 ;;=ADMINISTRATION OF DME^1^104
+155 ;;^UTILITY(U,$J,358.4,1403,0)
+156 ;;=DEMO OF METERED INHALER^10^104
+157 ;;^UTILITY(U,$J,358.4,1404,0)
+158 ;;=BLOOD TESTS^6^104
+159 ;;^UTILITY(U,$J,358.4,1405,0)
+160 ;;=BLADDER ^5^104
+161 ;;^UTILITY(U,$J,358.4,1406,0)
+162 ;;=BLOOD TRANSFUSION^7^104
+163 ;;^UTILITY(U,$J,358.4,1407,0)
+164 ;;=AIRWAY TREATMENTS^4^104
+165 ;;^UTILITY(U,$J,358.4,1408,0)
+166 ;;=BURN TREATMENT^8^104
+167 ;;^UTILITY(U,$J,358.4,1409,0)
+168 ;;=TB TEST^25^104
+169 ;;^UTILITY(U,$J,358.4,1410,0)
+170 ;;=REPAIR-SIMPLE-SCALP,NK,TRUNK^20^104
+171 ;;^UTILITY(U,$J,358.4,1411,0)
+172 ;;=REPAIR-SIMPLE-FACE,MUCOUS^19^104
+173 ;;^UTILITY(U,$J,358.4,1412,0)
+174 ;;=REPAIR-INTERM-SCALP,TRUNK^23^104
+175 ;;^UTILITY(U,$J,358.4,1413,0)
+176 ;;=REPAIR-INTERM-NK,HAND,FT,GENITALIA^22^104
+177 ;;^UTILITY(U,$J,358.4,1414,0)
+178 ;;=REPAIR-INTERM-FACE,MUCOUS^21^104
+179 ;;^UTILITY(U,$J,358.4,1415,0)
+180 ;;=OTHER^27^104
+181 ;;^UTILITY(U,$J,358.4,1416,0)
+182 ;;=PSYCHIATRY^17^104
+183 ;;^UTILITY(U,$J,358.4,1417,0)
+184 ;;=COVID-19 RELATED^9^104
+185 ;;^UTILITY(U,$J,358.4,1418,0)
+186 ;;=PC COMMON DIAGNOSES^1^105
+187 ;;^UTILITY(U,$J,358.4,1419,0)
+188 ;;=ADMINISTRATIVE TOPICS^15^105
+189 ;;^UTILITY(U,$J,358.4,1420,0)
+190 ;;=ANGINA^16^105
+191 ;;^UTILITY(U,$J,358.4,1421,0)
+192 ;;=ATHEROSCLEROSIS^17^105
+193 ;;^UTILITY(U,$J,358.4,1422,0)
+194 ;;=CARDIOVASCULAR^18^105
+195 ;;^UTILITY(U,$J,358.4,1423,0)
+196 ;;=DERMATOLOGY^22^105
+197 ;;^UTILITY(U,$J,358.4,1424,0)
+198 ;;=EAR DISORDERS^24^105
+199 ;;^UTILITY(U,$J,358.4,1425,0)
+200 ;;=EENT^25^105
+201 ;;^UTILITY(U,$J,358.4,1426,0)
+202 ;;=ENDOCRINE/METABOLIC^26^105
+203 ;;^UTILITY(U,$J,358.4,1427,0)
+204 ;;=EYE DISORDERS^27^105
+205 ;;^UTILITY(U,$J,358.4,1428,0)
+206 ;;=EYE INJURY^28^105
+207 ;;^UTILITY(U,$J,358.4,1429,0)
+208 ;;=GASTROENTEROLOGY^29^105
+209 ;;^UTILITY(U,$J,358.4,1430,0)
+210 ;;=GU/RENAL^30^105
+211 ;;^UTILITY(U,$J,358.4,1431,0)
+212 ;;=HEADACHE^31^105
+213 ;;^UTILITY(U,$J,358.4,1432,0)
+214 ;;=HEART VALVE DISEASE^32^105
+215 ;;^UTILITY(U,$J,358.4,1433,0)
+216 ;;=HEMATOLOGY/ONCOLOGY^33^105
+217 ;;^UTILITY(U,$J,358.4,1434,0)
+218 ;;=HISTORY OF ILLNESS^34^105
+219 ;;^UTILITY(U,$J,358.4,1435,0)
+220 ;;=INFECTIOUS DISEASE^35^105
+221 ;;^UTILITY(U,$J,358.4,1436,0)
+222 ;;=LIVER DISEASE^36^105
+223 ;;^UTILITY(U,$J,358.4,1437,0)
+224 ;;=MENTAL HEALTH^38^105
+225 ;;^UTILITY(U,$J,358.4,1438,0)
+226 ;;=MOVEMENT DISORDERS^39^105
+227 ;;^UTILITY(U,$J,358.4,1439,0)
+228 ;;=MUSCULOSKELETAL^40^105
+229 ;;^UTILITY(U,$J,358.4,1440,0)
+230 ;;=NEUROLOGY^41^105
+231 ;;^UTILITY(U,$J,358.4,1441,0)
+232 ;;=PAIN^42^105
+233 ;;^UTILITY(U,$J,358.4,1442,0)
+234 ;;=PREVENTIVE HEALTH^43^105
+235 ;;^UTILITY(U,$J,358.4,1443,0)
+236 ;;=PULMONARY^44^105
+237 ;;^UTILITY(U,$J,358.4,1444,0)
+238 ;;=SEXUAL TRAUMA^45^105
+239 ;;^UTILITY(U,$J,358.4,1445,0)
+240 ;;=SIGNS,SYMPTOMS,CONDITIONS^46^105
+241 ;;^UTILITY(U,$J,358.4,1446,0)
+242 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^47^105
+243 ;;^UTILITY(U,$J,358.4,1447,0)
+244 ;;=SUBSTANCE DISORDERS^48^105
+245 ;;^UTILITY(U,$J,358.4,1448,0)
+246 ;;=VARICOSE VEINS^50^105
+247 ;;^UTILITY(U,$J,358.4,1449,0)
+248 ;;=WOMEN'S HEALTH^51^105
+249 ;;^UTILITY(U,$J,358.4,1450,0)
+250 ;;=WOUNDS-INITIAL ENCOUNTER^52^105
+251 ;;^UTILITY(U,$J,358.4,1451,0)
+252 ;;=COMA^20^105
+253 ;;^UTILITY(U,$J,358.4,1452,0)
+254 ;;=CAUSES OF INJURY^19^105
+255 ;;^UTILITY(U,$J,358.4,1453,0)
+256 ;;=DEMENTIA^21^105
+257 ;;^UTILITY(U,$J,358.4,1454,0)
+258 ;;=LONG TERM CURRENT DRUG THERAPY^37^105
+259 ;;^UTILITY(U,$J,358.4,1455,0)
+260 ;;=ACQUIRED ABSENCE OF BODY PART(S)^2^105
+261 ;;^UTILITY(U,$J,358.4,1456,0)
+262 ;;=SUICIDE IDEATIONS/ATTEMPTS^49^105
+263 ;;^UTILITY(U,$J,358.4,1457,0)
+264 ;;=ACSC ACUTE KIDNEY FAILURE^3^105
+265 ;;^UTILITY(U,$J,358.4,1458,0)
+266 ;;=ACSC ANGINA^4^105
+267 ;;^UTILITY(U,$J,358.4,1459,0)
+268 ;;=ACSC ASTHMA/BRONCHITIS/COPD^5^105
+269 ;;^UTILITY(U,$J,358.4,1460,0)
+270 ;;=ACSC CHF^6^105
+271 ;;^UTILITY(U,$J,358.4,1461,0)
+272 ;;=ACSC DEHYDRATION^7^105
+273 ;;^UTILITY(U,$J,358.4,1462,0)
+274 ;;=ACSC DIABETES TYPE 1^8^105
+275 ;;^UTILITY(U,$J,358.4,1463,0)
+276 ;;=ACSC DIABETES TYPE 2^9^105
+277 ;;^UTILITY(U,$J,358.4,1464,0)
+278 ;;=ACSC HYPERTENSION^10^105
+279 ;;^UTILITY(U,$J,358.4,1465,0)
+280 ;;=ACSC INFECTIOUS GASTROENTERITIS^11^105
+281 ;;^UTILITY(U,$J,358.4,1466,0)
+282 ;;=ACSC PNEUMONIA^12^105
+283 ;;^UTILITY(U,$J,358.4,1467,0)
+284 ;;=ACSC UTI^13^105
+285 ;;^UTILITY(U,$J,358.4,1468,0)
+286 ;;=ACSC VIRAL ENTERITIS^14^105
+287 ;;^UTILITY(U,$J,358.4,1469,0)
+288 ;;=E-CIG/VAPE LUNG INJURY^23^105
+289 ;;^UTILITY(U,$J,358.4,1470,0)
+290 ;;=HEALTH/BEHAVIOR ASSESSMENT^1^106
+291 ;;^UTILITY(U,$J,358.4,1471,0)
+292 ;;=HEALTH/BEHAVIOR INTERVENTION^2^106
+293 ;;^UTILITY(U,$J,358.4,1472,0)
+294 ;;=PC COMMON DIAGNOSES^1^107
+295 ;;^UTILITY(U,$J,358.4,1473,0)
+296 ;;=ADMINISTRATIVE TOPICS^15^107
+297 ;;^UTILITY(U,$J,358.4,1474,0)
+298 ;;=ANGINA^16^107
+299 ;;^UTILITY(U,$J,358.4,1475,0)
+300 ;;=ATHEROSCLEROSIS^17^107
+301 ;;^UTILITY(U,$J,358.4,1476,0)
+302 ;;=CARDIOVASCULAR^18^107
+303 ;;^UTILITY(U,$J,358.4,1477,0)
+304 ;;=DERMATOLOGY^22^107
+305 ;;^UTILITY(U,$J,358.4,1478,0)
+306 ;;=EAR DISORDERS^24^107
+307 ;;^UTILITY(U,$J,358.4,1479,0)
+308 ;;=EENT^25^107
+309 ;;^UTILITY(U,$J,358.4,1480,0)
+310 ;;=ENDOCRINE/METABOLIC^26^107
+311 ;;^UTILITY(U,$J,358.4,1481,0)
+312 ;;=EYE DISORDERS^27^107
+313 ;;^UTILITY(U,$J,358.4,1482,0)
+314 ;;=EYE INJURY^28^107
+315 ;;^UTILITY(U,$J,358.4,1483,0)
+316 ;;=GASTROENTEROLOGY^29^107
+317 ;;^UTILITY(U,$J,358.4,1484,0)
+318 ;;=GU/RENAL^30^107
+319 ;;^UTILITY(U,$J,358.4,1485,0)
+320 ;;=HEADACHE^31^107
+321 ;;^UTILITY(U,$J,358.4,1486,0)
+322 ;;=HEART VALVE DISEASE^32^107
+323 ;;^UTILITY(U,$J,358.4,1487,0)
+324 ;;=HEMATOLOGY/ONCOLOGY^33^107
+325 ;;^UTILITY(U,$J,358.4,1488,0)
+326 ;;=HISTORY OF ILLNESS^34^107
+327 ;;^UTILITY(U,$J,358.4,1489,0)
+328 ;;=INFECTIOUS DISEASE^35^107
+329 ;;^UTILITY(U,$J,358.4,1490,0)
+330 ;;=LIVER DISEASE^36^107
+331 ;;^UTILITY(U,$J,358.4,1491,0)
+332 ;;=MENTAL HEALTH^38^107
+333 ;;^UTILITY(U,$J,358.4,1492,0)
+334 ;;=MOVEMENT DISORDERS^39^107
+335 ;;^UTILITY(U,$J,358.4,1493,0)
+336 ;;=MUSCULOSKELETAL^40^107
+337 ;;^UTILITY(U,$J,358.4,1494,0)
+338 ;;=NEUROLOGY^41^107
+339 ;;^UTILITY(U,$J,358.4,1495,0)
+340 ;;=PAIN^42^107
+341 ;;^UTILITY(U,$J,358.4,1496,0)
+342 ;;=PREVENTIVE HEALTH^43^107
+343 ;;^UTILITY(U,$J,358.4,1497,0)
+344 ;;=PULMONARY^44^107
+345 ;;^UTILITY(U,$J,358.4,1498,0)
+346 ;;=SEXUAL TRAUMA^45^107
+347 ;;^UTILITY(U,$J,358.4,1499,0)
+348 ;;=SIGNS,SYMPTOMS,CONDITIONS^46^107
+349 ;;^UTILITY(U,$J,358.4,1500,0)
+350 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^47^107
+351 ;;^UTILITY(U,$J,358.4,1501,0)
+352 ;;=SUBSTANCE DISORDERS^48^107
+353 ;;^UTILITY(U,$J,358.4,1502,0)
+354 ;;=VARICOSE VEINS^50^107
+355 ;;^UTILITY(U,$J,358.4,1503,0)
+356 ;;=WOMEN'S HEALTH^51^107
+357 ;;^UTILITY(U,$J,358.4,1504,0)
+358 ;;=WOUNDS-INITIAL ENCOUNTER^52^107
+359 ;;^UTILITY(U,$J,358.4,1505,0)
+360 ;;=COMA^20^107
+361 ;;^UTILITY(U,$J,358.4,1506,0)
+362 ;;=CAUSES OF INJURY^19^107
+363 ;;^UTILITY(U,$J,358.4,1507,0)
+364 ;;=DEMENTIA^21^107
+365 ;;^UTILITY(U,$J,358.4,1508,0)
+366 ;;=LONG TERM CURRENT DRUG THERAPY^37^107
+367 ;;^UTILITY(U,$J,358.4,1509,0)
+368 ;;=ACQUIRED ABSENCE OF BODY PART(S)^2^107
+369 ;;^UTILITY(U,$J,358.4,1510,0)
+370 ;;=SUICIDE IDEATIONS/ATTEMPTS^49^107
+371 ;;^UTILITY(U,$J,358.4,1511,0)
+372 ;;=ACSC ACUTE KIDNEY FAILURE^3^107
+373 ;;^UTILITY(U,$J,358.4,1512,0)
+374 ;;=ACSC ANGINA^4^107
+375 ;;^UTILITY(U,$J,358.4,1513,0)
+376 ;;=ACSC ASTHMA/BRONCHITIS/COPD^5^107
+377 ;;^UTILITY(U,$J,358.4,1514,0)
+378 ;;=ACSC CHF^6^107
+379 ;;^UTILITY(U,$J,358.4,1515,0)
+380 ;;=ACSC DEHYDRATION^7^107
+381 ;;^UTILITY(U,$J,358.4,1516,0)
+382 ;;=ACSC DIABETES TYPE 1^8^107
+383 ;;^UTILITY(U,$J,358.4,1517,0)
+384 ;;=ACSC DIABETES TYPE 2^9^107
+385 ;;^UTILITY(U,$J,358.4,1518,0)
+386 ;;=ACSC HYPERTENSION^10^107
+387 ;;^UTILITY(U,$J,358.4,1519,0)
+388 ;;=ACSC INFECTIOUS GASTROENTERITIS^11^107
+389 ;;^UTILITY(U,$J,358.4,1520,0)
+390 ;;=ACSC PNEUMONIA^12^107
+391 ;;^UTILITY(U,$J,358.4,1521,0)
+392 ;;=ACSC UTI^13^107
+393 ;;^UTILITY(U,$J,358.4,1522,0)
+394 ;;=ACSC VIRAL ENTERITIS^14^107
+395 ;;^UTILITY(U,$J,358.4,1523,0)
+396 ;;=E-CIG/VAPE LUNG INJURY^23^107
+397 ;;^UTILITY(U,$J,358.4,1524,0)
+398 ;;=COVID-19 CONFIRMED^2^108
+399 ;;^UTILITY(U,$J,358.4,1525,0)
+400 ;;=COVID-19 EXPOSURE^3^108
+401 ;;^UTILITY(U,$J,358.4,1526,0)
+402 ;;=COVID-19 RELATED COND/SYMP^5^108
+403 ;;^UTILITY(U,$J,358.4,1527,0)
+404 ;;=COVID-19 SCREEN^1^108
+405 ;;^UTILITY(U,$J,358.4,1528,0)
+406 ;;=COVID-19 PRE-OP^4^108
+407 ;;^UTILITY(U,$J,358.4,1529,0)
+408 ;;=COVID-19 VACCINE STATUS^6^108
+409 ;;^UTILITY(U,$J,358.4,1530,0)
+410 ;;=COVID-19 ^1^109
+411 ;;^UTILITY(U,$J,358.4,1531,0)
+412 ;;=COVID-19 CONFIRMED^2^110
+413 ;;^UTILITY(U,$J,358.4,1532,0)
+414 ;;=COVID-19 EXPOSURE^3^110
+415 ;;^UTILITY(U,$J,358.4,1533,0)
+416 ;;=COVID-19 RELATED COND/SYMP^5^110
+417 ;;^UTILITY(U,$J,358.4,1534,0)
+418 ;;=COVID-19 SCREEN^1^110
+419 ;;^UTILITY(U,$J,358.4,1535,0)
+420 ;;=COVID-19 PRE-OP^4^110
+421 ;;^UTILITY(U,$J,358.4,1536,0)
+422 ;;=COVID-19 VACCINE STATUS^6^110
